Santangel's Review

Commentary

Jonathan Goodman

Jonathan Goodman is the CEO of Knight Therapeutics, a publicly traded pharmaceutical company. Jonathan was the CEO of Paladin Labs, which he grew from $6 million in revenue to $270 million. In 2014 Jonathan sold Paladin for $3 billion, a 100 fold return from the IPO listing. (Read More)